Ignite Creation Date:
2024-05-06 @ 9:41 AM
Last Modification Date:
2024-10-26 @ 12:17 PM
Study NCT ID:
NCT03040999
Status:
COMPLETED
Last Update Posted:
2024-02-26
First Post:
2017-02-01
Brief Title:
Study of Pembrolizumab MK-3475 or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma MK-3475-412KEYNOTE-412
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Neoplasms |